Entia Biosciences Inc ERGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.03 / $0.05
- Market Cap
- $33.66
- Volume/Avg
- 145,072 / 80,036
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 7
- Website
- http://www.entiabio.com
Valuation
|
Metric
|
ERGO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ERGO
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.11 |
Interest Coverage | −15.71 |
Quick Ratio
ERGO
Profitability
|
Metric
|
ERGO
|
|---|---|
Return on Assets (Normalized) | −278.64% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ERGO
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Cmtvwqxqw | Snkxk | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Htynwyyz | Cmtzqq | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Nrfmwrzp | Rnvchl | $118.7 Bil | |||
| Moderna Inc
MRNA
| Scgkntdn | Kmp | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Zdvvfxpk | Ptnqh | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Yywvzvhb | Mkpn | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Jjxvmhn | Sptdl | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Vpwwygrj | Wpqdy | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Bllmtgtn | Pykz | $15.0 Bil | |||
| Incyte Corp
INCY
| Wrzcsdzys | Cwrpqn | $13.5 Bil |